Helix BioPharma Corp.

Helix BioPharma Corp.verified

HBP.TO

Price:

$2.1

Market Cap:

$160.39M

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered ...[Read more]

Industry

Biotechnology

IPO Date

1996-08-13

Stock Exchange

TSX

Ticker

HBP.TO

The Enterprise Value as of December 2025 (TTM) for Helix BioPharma Corp. (HBP.TO) is 160.66M

According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 160.66M. This represents a change of 520.67% compared to the average of 25.89M of the last 4 quarters.

Helix BioPharma Corp. (HBP.TO) Historical Enterprise Value (quarterly & annually)

How has HBP.TO Enterprise Value performed in the past?

The mean historical Enterprise Value of Helix BioPharma Corp. over the last ten years is 72.22M. The current 160.66M Enterprise Value has changed 22.15% with respect to the historical average. Over the past ten years (40 quarters), HBP.TO's Enterprise Value was at its highest in in the April 2020 quarter at 204.03M. The Enterprise Value was at its lowest in in the January 2025 quarter at 7.22M.

Quarterly (TTM)
Annual

Average

72.22M

Median

62.40M

Minimum

27.62M

Maximum

154.62M

Helix BioPharma Corp. (HBP.TO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Helix BioPharma Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 76.45%

Maximum Annual Enterprise Value = 154.62M

Minimum Annual Increase = -75.88%

Minimum Annual Enterprise Value = 27.62M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202559.91M19.63%
202450.08M25.92%
202339.77M44.00%
202227.62M-75.88%
2021114.49M76.45%
202064.89M9.03%
201959.52M-14.47%
201869.58M-14.85%
201781.72M-47.15%
2016154.62M2.27%

Helix BioPharma Corp. (HBP.TO) Average Enterprise Value

How has HBP.TO Enterprise Value performed in the past?

The current Enterprise Value of Helix BioPharma Corp. (HBP.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

49.92M

5-year avg

58.37M

10-year avg

72.22M

Helix BioPharma Corp. (HBP.TO) Enterprise Value vs. Peers

How is HBP.TO’s Enterprise Value compared to its peers?

Helix BioPharma Corp.’s Enterprise Value is less than Jushi Holdings Inc. (399.81M), greater than Satellos Bioscience Inc. (41.10M), greater than Cybin Inc. (145.60M), less than Cannara Biotech Inc. (196.59M), greater than HLS Therapeutics Inc. (150.27M), greater than Medicenna Therapeutics Corp. (55.99M), greater than Cardiol Therapeutics Inc. (109.97M), less than Quipt Home Medical Corp. (194.62M), greater than Sernova Corp. (47.11M), greater than Resverlogix Corp. (29.39M),

Build a custom stock screener for Helix BioPharma Corp. (HBP.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Helix BioPharma Corp. (HBP.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Helix BioPharma Corp.'s Enterprise Value?

What is the highest Enterprise Value for Helix BioPharma Corp. (HBP.TO)?

What is the 3-year average Enterprise Value for Helix BioPharma Corp. (HBP.TO)?

What is the 5-year average Enterprise Value for Helix BioPharma Corp. (HBP.TO)?

How does the current Enterprise Value for Helix BioPharma Corp. (HBP.TO) compare to its historical average?